India Licensing Partnership Advisory
From FDA-Approved Asset to India Revenue in 12–18 Months
India Licensing Partnership Advisory
U.S. Governance & Strategy + India Scale & Execution — Seamless Integration
eteraflex Connect is the only US-headquartered partner offering comprehensive end-to-end India licensing support—integrating regulatory strategy, clinical execution, and market access through a single point of accountability.
- 4–5 Week CDSCO Approvals (vs. 12–16 weeks average)
- 45–65% Cost Reduction vs. US/EU
- 18+ Years Bridging U.S. Sponsors & Indian Pharma
India Is Becoming a Strategic Commercialization Market
India’s pharmaceutical market — currently valued at ~$50 billion — is projected to reach $130 billion by 2030. With NDCT Amendment Rules 2026 and expanded bridge-study waiver pathways, global sponsors now have a unique opportunity to license innovative therapies into one of the world’s fastest-growing patient populations.
Rapid growth in biosimilars and specialty therapies | Strong government support for global partnerships | High unmet need in oncology, immunology, rare diseases, and chronic care
Our India Licensing Partnership Capabilities
One Partner. Complete End-to-End Support.
Our integrated U.S.–India platform manages the full licensing journey — from regulatory strategy to commercial launch:
01
Regulatory Strategy & Waiver Engineering
ICH E5 ethnic sensitivity analysis, bridge-study waiver strategy, CDSCO submission support, and expert committee preparation.
02
Bridge Study Design & Execution
PK/PD and confirmatory bridging studies executed with U.S.-standard biostatistics, clinical operations, and data oversight.
03
Partner Identification & Deal Facilitation
Identification, evaluation, and structured licensing partnerships with leading Indian pharmaceutical companies.
04
Market Access & Lifecycle Management
Pricing strategy, reimbursement pathways, KOL engagement, launch readiness, and ongoing regulatory lifecycle support.
Our model eliminates fragmentation — delivering faster approvals, stronger partnerships, and predictable commercialization outcomes.
How We Deliver
eteraflex ensures seamless India licensing execution through a structured, end-to-end advisory and operational framework:
- Strategic Regulatory Planning: Pathway optimization aligned with CDSCO requirements
- Accelerated Approval Execution: Proven processes for rapid regulatory clearances
- Integrated Clinical & Regulatory Delivery: Bridging studies, submissions, and compliance under one system
- Partner Ecosystem Access: Strong network of Indian pharma companies for licensing deals
- Commercial Readiness Support: Market access strategy and launch preparation
Our integrated approach enables faster entry, reduced cost, and scalable growth in the India market.
Technology & Quality
Regulatory Intelligence Platform — Built for Speed & Market Success
eteraflex connects leverages proprietary regulatory intelligence and data-driven systems to streamline India market entry and lifecycle management.
Platform Advantages
- Real-time CDSCO regulatory tracking and updates
- Data-driven decision-making for pathway optimization
- Standardized submission frameworks for faster approvals
- Integrated regulatory + commercial insights
- Centralized documentation and audit readiness
Quality & Compliance Framework
- Continuous regulatory monitoring and compliance tracking
- Risk-based regulatory strategy and execution
- Strong audit trail and documentation control
- Post-approval lifecycle and label expansion support
- Long-term compliance and market sustainability
A Trusted U.S.–India Licensing Platform
Our integrated platform combines U.S. strategic governance with India execution scale — enabling reliable, fast, and cost-efficient market entry.
U.S. Governance & Sponsor Trust
Princeton, NJ headquarters with deep expertise in global regulatory strategy and FDA-aligned execution.
India Scale & Execution
Multi-city India operations delivering speed, cost efficiency, and strong local regulatory expertise.
Integrated U.S.–India Platform
Single accountable partner combining global strategy with local execution — ensuring seamless delivery.
Take the Next Step Today
Choose one of the options below and get started
Download Playbook
India Licensing Playbook 2026 with regulatory updates, market insights, and practical guidance.
Request Opportunity Overview
Get a high-level India opportunity overview tailored for your program.
Schedule Strategy Call
